×

img Acces sibility Controls

Research Projects Banner

Research Projects

studies on the alterations of nuclear speckle and paraspeckle components upon HCV infection: possible consequences in hepatocellular carcinoma

Implementing Organization

Indian Institute of Science
Principal Investigator
Ms. Piyanki Das
Indian Institute of Science

Project Overview

The heterogeneous nucleoplasm consists of various self-organizing nuclear bodies, with nuclear speckles and its subregion paraspeckles being dominant. HCV, a cytoplasmic replicating virus, interacts with the nucleus and contributes to malignant transformation of hepatocytes. Persistent viral infection-associated stress and stress body formation serve as oncogenic stress factors for hepatocyte transformation and growth promotion during HCV-associated disorders. Recent research has revealed the interaction of cellular lncRNA and microRNA with nuclear speckled and paraspeckle subnuclear components and their role as oncogenic regulatory transcripts. Under various diseases, these nuclear body components are reshaped, destabilizing nuclear speckled factors and affecting RNA metabolism and gene expression regulation, leading to tumorigenesis and rare disorders. The lab is actively working on the role of several RNA binding proteins, long non-coding RNAs, and micro RNAs, paraspeckle components during virus-induced cellular pathogenesis in different RNA virus models, including HCC. The hypothesis is that HCV infection-induced oncogenic stress body reshaped nuclear speckle structures plays a prime role in determining viral replication and persistent infection, boosting regulatory control of cell fate and contributing to the development of hepatocellular carcinoma.
Funding Organization
Funding Organization
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Oncology
Start Year
2024
End Year
2026
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop